K. Kubo

发表

Rapid reduction in BCR‐ABL1 transcript predicts deep molecular response in dasatinib‐treated chronic‐phase chronic myeloid leukaemia patients

J. Sakamoto, T. Nagashima, T. Kondo, 2018, European journal of haematology.

Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study

T. Naoe, A. Wakita, R. Ueda, 2012, International Journal of Hematology.

Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma

S. Iida, M. Tohkin, K. Kubo, 2020, Cancer science.

PHARMACOKINETICS AND DISPOSITION Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia

T. Nagashima, T. Kondo, K. Murai, 2016 .

A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia

H. Iwasaki, T. Naoe, M. Taniwaki, 2022, International Journal of Hematology.

Monitoring twenty-six chronic myeloid leukemia patients by BCR-ABL mRNA level in bone marrow:a single hospital experience.

K. Kubo, T. Akagi, K. Ogura, 2011, Acta medica Okayama.

Outcome From a Randomized Controlled Clinical Trial　- Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT).

T. Tsukamoto, K. Kubo, M. Nishikido, 2018, Circulation journal : official journal of the Japanese Circulation Society.

A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia‐chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria

J. Sakamoto, K. Ishizawa, K. Murai, 2015, European journal of haematology.

The potential of patients' peripheral blood mononuclear cells to differentiate into dendritic cells after hematopoietic stem cell transplantation.

Kenji Takahashi, I. Kashiwakura, K. Kubo, 2011, Life sciences.

Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200

T. Naoe, A. Wakita, Takuhiro Yamaguchi, 2018, Annals of Hematology.

Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.

M. Taniwaki, M. Tanimoto, T. Miyamoto, 2016, Leukemia research.

[Intracranial granulocytic sarcoma in a patient with acute myeloid leukemia].

K. Kubo, Tomoo Inoue, Shinjitsu Nishimura, 2006, No to shinkei = Brain and nerve.

A randomized, double‐blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma

K. Kubo, T. Hotta, A. Urabe, 2016, British journal of haematology.

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

K. Ohta, M. Matsumoto, K. Ohashi, 2019, International Journal of Hematology.

Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation

K. Sakamoto, J. Kanda, S. Kako, 2021, Bone Marrow Transplantation.

A high CD34+ cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors

M. Kurokawa, K. Kubo, S. Chiba, 2020, Bone Marrow Transplantation.

A single high‐resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low‐resolution HLA mismatch

J. Kanda, Y. Kanda, T. Miyamoto, 2015, American journal of hematology.

Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.

K. Kubo, Yuichi Sakamoto, Y. Mariya, 2012, The Tohoku journal of experimental medicine.

Quantification of EBV DNA in Chronic Active EBV Infection

K. Kubo, Yuichi Sakamoto, Y. Mariya, 2012 .

Suspected Pulmonary Infection with Trichoderma longibrachiatum after Allogeneic Stem Cell Transplantation

K. Kubo, T. Akagi, C. Kawamura, 2017, Internal medicine.

Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia

T. Nagashima, T. Kondo, K. Murai, 2016, European Journal of Clinical Pharmacology.

High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry.

R. Suzuki, K. Izutsu, D. Chihara, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry

K. Matsuo, Y. Kanda, Y. Kodera, 2010, International journal of hematology.

Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis.

Yusuke Nakamura, Tatsuhiko Tsunoda, Ryuzo Ohno, 2002, Molecular cancer therapeutics.

Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT

J. Kanda, Y. Kanda, T. Miyamoto, 2014, Bone Marrow Transplantation.

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

M. Taniwaki, S. Iida, T. Kinoshita, 2018, International Journal of Hematology.

Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study

H. Matsuoka, K. Kirito, I. Matsumura, 2022, Cancer medicine.

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia

T. Naoe, S. Fujiwara, M. Kizaki, 2021, International Journal of Clinical Oncology.

Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial

K. Murai, S. Ito, T. Oyake, 2016, European journal of haematology.

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

M. Taniwaki, M. Tanimoto, T. Miyamoto, 2014 .

A CASE OF ACUTE MYELOID LEUKEMIA WITH PLATELET TRANSFUSION IN A REFRACTORY STATE DUE TO ANTI-HPA-5a ANTIBODY BEFORE INITIAL REMISSION INDUCTION THERAPY

K. Kubo, Hirotake Sakuraba, Kohei Yamaguchi, 2024, Japanese Journal of Transfusion and Cell Therapy.